Cysteine-free peptides in scorpion venom: Geographical distribution, structure-function relationship and mode of action

African Journal of Biotechnology

Volumn 5, Issue 25, 2006, Pages 2495-2502

  Elgar, Dale ^a   Du Plessis, Johan ^a   Du Plessis, Lissinda ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Cysteine free peptides; Scorpion venom

Indexed keywords

CALCIUM CHANNEL; CYSTEINE FREE PEPTIDE; HADRURIN; PARABUTOPORIN; PEPTIDE DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; POTASSIUM CHANNEL; RYANODINE; SCORPION VENOM; SODIUM CHANNEL; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIMICROBIAL ACTIVITY; GEOGRAPHIC DISTRIBUTION; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SCORPION;

BACTERIA (MICROORGANISMS); SCORPIONES;

EID: 33846327193     PISSN: None     EISSN: 16845315     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Ali A, Stoeva S, Schutz J, Kayed R, Abassi A, Zaidi ZH, Voelter W. (1998). Purification and primary structure of low molecular mass peptides from scorpion (Buthus sindicus) venom. Comp Biochem Physiol (Part A) 121:323-32.
2. Belokoneva OS, Villegas E, Corzo G, Dai L, Nakajima T (2003). The hemolytic activity of six arachnid cationic peptides is affected by the phosphatidylcholine-to-sphingomyelin ratio lipid bilayers. Biochim Biophys Acta 1617:22-30.
3. Berchinger B (1997). Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin. J Membr Biol 156:197-211.
4. Chowell, G, Díaz-Dueas P, Bustos-Saldańa R, Alemán Mireles A, Fet V (2006). Epidemiological and clinical characteristics of scorpionism in Colima, Mexico (2000-2001). Toxicon 47:753-758.
5. Corzo G, Escoubas P, Villegas E, Barnham KJ, He W, Norton RS, Nakajima T (2001). Characterization of unique amphipathic antimicrobial peptides from the venom of the scorpion Pandinus imperator. Biochem J 359:35-45.
6. Dai L, Yasuda A, Naoki H, Corzo G, Andriantsiferana M, Nakajima T (2001). IsCT, a novel cytotoxic linear peptide from scorpion Opisthacanthus madagascariensis. Biochem Biophys Res Commun 286:820-5.
7. Dai L, Corzo G, Naoki H, Andriantsiferana M, Nakajima T (2002). Purification, structure-function analysis, and molecular characterrization of novel linear peptides from scorpion Opisthacanthus madagascariensis. Biochem Biophys Res Commun 293:1514-22.
8. Debin JA, Maggio JE, Strichartz GR (1993). Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. Am J Physiol 264: C361-9.
9. Du Plessis JL (1997). Porievorming deur venoom van Parabuthus schlechteri en verskeie Opistophthalmus spesies. Potchefstroom : Potchefstroom University for CHE (Dissertation - M.Sc.)
10. Elgar D, Verdonck F, Grobler A, Fourie C, Du Plessis J (2006a). Ion selectivity of scorpion toxin-induced pores in cardiac myocytes. Peptides 27(1): 56-61.
11. Elgar D, Verdonck F, Grobler A, Fourie C, Du Plessis J (2006b). The use of confocal microscopy in quantifying changes in membrane potential. Afr J Biotechnol 5(13): 1303-7.
12. Ferreira LAF, Alves EW, Henriques OB, Henriques OB. Peptide T (1993). A novel Bradykinin-potentiating peptide isolated from Tityus serrulatus scorpion venom. Toxicon 31: 941-7.
13. Genco CA, Maloy WL, Kari UP, Motley M (2003). Antimicrobial activity of magainin analogues against anaerobic oral pathogens. Internat J Antimicrob Agents 21:75-78.
14. Gilles N, Leipold E, Chen H, Heinemann SH, Gordon D (2001). Effect of depolarization on binding kinetics of scorpion α-toxin highlights conformational changes of rat brain sodium channels. Biochem 40: 14576-84.
15. Hancock REW (2001). Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis; 1:156-64.
16. Hancock REW, Lehrer R (1998). Cationic peptides: a new source of antibiotics. TIBTECH 16: 82-7.
17. Jain MK, Indurkar M, Kastwar V, Malviya S. (2006). Myocarditis and Multiple Cerebral and Cerebellar Infarction Following Scorpion Sting. JAPI 54:491-2.
18. Lehmann J, Retz M, Sidhu SS, Suttmann H, Sell M, Paulsen F, Harder J, Unteregger G, Stöckle M. Antitumor (2006). Activity of the Antimicrobial Peptide Magainin II against Bladder Cancer Cell Lines. Europ Urol 50:141-147.
19. Ludtke SJ, He K, Heller WT, Harroun TA, Yang L, Huang HW (1996). Membrane pores induced by magainin. Biochem 35(43): 13723-28.
20. Meki AMA, Nassar AY, Rochat H. A bradykinin-potentiating peptide (peptide K 12) isolated from the venom of Egyptian scorpion Buthus occitanus. Peptides 1995;16:1359-65.
21. Moeman L. Identification and biological activities of α-helical, antimicrobial peptides in the venom of scorpions. PhD-Thesis, Leuven : Belgium; 2002, 143p.
22. Moerman L, Bosteels S, Noppe W, Willems J, Clynen E, Schoos L (2002). Antibacterial and antifungal properties of α-helical, cationic peptides in the venom of scorpions from southern Africa. Eur. J. Biochem 269: 4799-810.
23. 2+ signaling in HL-60 cells. Biochem Biophys Res Commun 311: 90-7.
24. Possani LD, Merino E, Corona M, Bolivar F, Becerril B (2000). Peptides and genes coding for scorpion toxins that affect ion-channels. Biochemie 82: 861-8.
25. + channels and related peptides: biodiversity, structure-function relationships and evolution. Toxicon 46: 831-44.
26. +-channels. Toxicon 43: 865-75.
27. Sato H, Feix JB (2006). Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic α-helical antimicrobial peptides. Biochim Biophys Acta In Corrected Press.
28. Shai Y (1999). Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochem Biophys Acta - Biomemb 1462(1-2): 55-70.
29. Simard MJ, Watt DD (2004). Venoms and toxins. In: Polis GA, editor. The biology of scorpions, New York: Stanford University Press, 1990, p. 414-44.
30. Stewart JM. Bradykinin antagonists: discovery and development. Peptides 25: 527-32.
31. Torres-Larios A, Gurrola GB, Zamudio FZ, Possani LD (2000). Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus. Eur J Biochem 267: 5023-31.
32. Tossi A, Sandri L, Giangaspero A (2000). Amphipathic, α-helical antimicrobial peptides. Biopolymers 55: 4-30.
33. Valdivia HH, Possani LD (1998). Peptide toxins as probes of ryanodine receptor structure and function. Trends Cardiovas Med 8: 111-8.
34. Verdonck F, Bosteels S, Desmet J, Moerman L, Noppe W, Willems J (2000). A novel class of pore-forming peptides from the venom of Parabuthus schlechteri Purcell (Scorpions: Buthidae). Cimbebasia 16: 247-60.
35. Willems J, Noppe W, Moerman L, van der Walt J, Verdonck F (2002). Cationic peptides from scorpion venom can stimulate and inhibit polymorphonuclear granulocytes. Toxicon 40:1679-83.
36. Yedery RD, Reddy KVR (2005). Antimicrobial peptides as microbicidal contraceptives: prophecies for prophylactics - a mini review. Euro J Contracep Reprod Health Care 10(1): 32-42.
37. Zasloff M (2002). Antimicrobial peptides of multicellular organisms. Nature 415: 389-95.
38. Zeng X, Li W, Peng F, Zhu Z (2000). Cloning and characterization of a novel cDNA sequence encoding the precursor of a novel venom peptide (BmKbpp) related to a bradykinin-potentiating peptide from the Chinese scorpion Buthus martensii Karsch. IUBMB Life 49: 207-10.
39. Zeng X-C, Li W-X, Wang S-X, Zhu S-Y, Luo F (2001). Precursor of a novel scorpion venom peptide (BmKn1) with no disulphide bridge from Buthus martensii Karsch. IUBMB Life 51: 117-20.
40. Zeng X-C, Wang S-X, Zhu Y, Zhu S-Y, Li W-X (2004). Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch. Peptides ;25: 143-50.
41. Zeng X-C, Corzo G, Hahin R (2005). Scorpion venom peptides without disulfide bridges. IUBMB Life 57(1): 13-21.